Versiti’s donor red blood cell genotyping helps you build a well-characterized donor pool so you can meet the transfusion needs of future patients. Our service covers common and rare antigens, including those found in patients with sickle cell disease and thalassemia. Compared to serological antigen typing, Versiti’s high-throughput approach provides cost savings and supports patient care.

Versiti’s donor screening service will help you:

• Potentially reduce donor RBC antigen screening costs
• Quickly identify antigen-negative units
• Provide excellent patient care

Versiti’s patient red blood cell (RBC) genotyping panel provides you with the accuracy and confidence to ensure the highest quality of transfusion patient care. Our genotyping service allows you to characterize the alleles associated with clinically significant blood group antigens before or during treatment. These panels are especially beneficial for patients presenting with warm autoantibodies, positive DATs and those who have been recently transfused.

Our panels fulfill all the requirements needed in today’s transfusion medicine:

• Clinically significant antigens
• Rapid turnaround time of less than 72 hours
• Market-sensitive pricing

Versiti is a pioneer in prenatal red blood cell genotyping. We began offering this testing in 1995 and have more than 25 years of experience in hemolytic disease of the newborn. Our physicians are always available to consult on high-risk pregnancy management, including intrauterine transfusions.

Versiti’s prenatal red blood cell genotyping services include:

• Single antigen system testing
• Case-based evaluations of mother, father and fetus
• Antigen-negative and CMV-negative red cell products for intrauterine transfusions